Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Japan’s Fusosha Publishing signs agreement for use of Cxense software

Oslo, Norway – 2 July 2018 – Cxense ASA (OSE: CXENSE) today announced that the Japanese publisher of magazines and books Fusosha Publishing Inc. has signed an agreement to use Cxense’s Data Management Platform (DMP) and Personalization software.The company is a subsidiary of the Japanese multimedia group Fuji Media Holdings, and publishes a wide range of magazines, books and mooks, the latter being a hybrid of books and magazines intended to remain on bookstore shelves for longer periods than traditional magazines. The publications are available for sale through the company’s e-commerce

QuickBit eu AB (publ) hires Jonathan Widinghoff as Legal Counsel

QuickBit eu AB (publ) has hired Jonathan Widinghoff as Legal Counsel. Jonathan is an experienced legal professional with a specialty in startups and fintech companies. He joins QuickBit from the investment and reconstruction company FrontOffice Nordic AB (publ).At QuickBit, Jonathan will be responsible for coordinating legal matters internally and externally, his remit will include compliance with regulations for operations made by the Gibraltar company, legal issues regarding the listing of QuickBit, data protection, contract law and general business law issues. In addition to his LL.M.

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January – June 2018. The presentation will be held in English.Time: Friday 13 July, 2018 at 10.00 a.m. CET. Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 506 921 69  International dial in number: +44 (0) 203 0095709  Conference name: Vitrolife, conference ID: 7061869 Vitrolife participants:Thomas Axelsson, CEO Mikael Engblom, CFOThe press release for Vitrolife’s Report on Operations will be

ATG selects Evolution Live Casino as Swedish market re-regulates

Evolution Gaming, leading provider of Live Casino solutions, has announced that is has signed an agreement to supply Live Casino services to Swedish horse racing operator AB Trav och Galopp (ATG), when Sweden’s new gambling law is set to take effect 1 January 2019.The news follows the approval on 7 June 2018 by Sweden’s national legislature, the Riksdag, of legislation for the re-regulation of Sweden’s gambling market. Traditionally, ATG’s business activity has been regulated by a contract between ATG's owners, the Swedish Trotting Association and the Swedish Jockey Club, and the Swedish

Recommended voluntary cash offer to acquire all shares in LINK Mobility Group ASA by Victory Partners VIII Norway AS

Recommended voluntary cash offer to acquire all shares in LINK Mobility Group ASA by Victory Partners VIII Norway AS ·  Voluntary cash offer at NOK 225.0 per issued and outstanding share (“Shares”) in LINK Mobility Group ASA (“LINK Mobility” or the “Company”), valuing the total share capital of LINK Mobility at approximately NOK 3,396 million. ·  Premium of 27.4% over the closing price of the shares on June 29th, 2018 and 44.5%, 51.7%, and 71.5% over the volume weighted average price (“VWAP”) of the Company’s Shares for the three, six and twelve month periods prior to this

Thailand’s Nation Multimedia Group signs agreement for Cxense software

Oslo, Norway – 2 July 2018 – Cxense ASA (OSE: CXENSE) today announced that the Thai media company Nation Multimedia Group PCL has signed an agreement to use Cxense’s Data Management Platform (DMP) and Personalization software.Nation is one of the largest Thai media groups and is listed on the Stock Exchange of Thailand. The company operates two digital TV stations, the English-language newspaper The Nation, two Thai newspapers and a publishing house.Nation will deploy Cxense DMP and personalization software to improve user insight, and to drive engagement and advertising revenue across

NOTICE OF BIOHIT OYJ’S EXTRAORDINARY GENERAL MEETING

---------------------------------------------------------------------- Biohit Oyj Stock Exchange Release July 2, 2018 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the Extraordinary General Meeting of Biohit Oyj to be held on Thursday, August 16, 2018 starting at 4:00 pm at Vanha Ylioppilastalo. The address is Mannerheimintie 3, 00100 Helsinki. The reception of shareholders registered for the meeting and the distribution of voting slips will commence at 3:00 pm. Coffee will be served. A. Matters on the agenda of the Extraordinary General Meeting 1.

JM acquiring property in Espoo, Helsinki

JM is acquiring a centrally located school property in Leppävaara, Espoo in the Greater Helsinki area. The property’s detailed plan has gained final approval for 850 apartments.The deal is worth SEK 240m and will be reported in Q2 2018 under the JM International business segment. Payment will be made in Q3 2018. The acquired property is centrally located in Leppävaara, Espoo, close to both the Sello shopping center and the bus and train station. Current school activities will be moved to new premises at a different location.  “The property is nicely situated in Leppävaara, and is within

EQT to acquire leading open source software provider SUSE

· EQT VIII to acquire SUSE, a leading global provider of open source infrastructure software for enterprises · EQT VIII is partnering with CEO Nils Brauckmann and his team to support SUSE’s next period of growth and innovation, and to strengthen its position as leading open source player both organically and through add-on acquisitions · SUSE to further build its brand and unique corporate culture as a stand-alone business The EQT VIII fund (“EQT” or “EQT VIII”) has agreed to acquire SUSE, a leading global provider of open source infrastructure software for large enterprises,

Imfinzi approved in Japan for Stage III nsclc

02 July 2018 07:00 BST Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer Imfinzi is the only immunotherapy approved for unresectable Stage III NSCLC Approval is based on the Phase III PACIFIC trial AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the Japanese Ministry of Health, Labour and Welfare approved Imfinzi (durvalumab) as maintenance therapy after definitive chemoradiation therapy (CRT) in locally-advanced (Stage III), unresectable non-small cell lung cancer (NSCLC). Dave Fredrickson,

Autoliv completes spin-off

(Stockholm, Sweden, July 2, 2018) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb) the worldwide leader in automotive safety systems, today announced the completion of the spin-off of its electronics segment, Veoneer, Inc.With the completion of the spin-off, Veoneer, Inc. will today begin regular way trading on the New York Stock Exchange and will begin trading on Nasdaq Stockholm as an independent company. Prior to the spin-off and as previously announced, Autoliv made cash contributions to Veoneer so that Veoneer has total cash liquidity of approximately $1 billion. Autoliv funded the

Bactiguard takes the next step in China and signs agreement worth more than SEK 30 million

Bactiguard takes the next step in China and accelerates its ambitions through a combined distribution and license agreement with Well Lead Medical (Well Lead) with an initial value of more than SEK 30 million. At the same time, the cooperation with the current distributor Jian AN is terminated and Bactiguard pays a compensation of approximately SEK 11 million.The agreement with Well Lead, China's leading manufacturer of consumable medical devices, includes all products in Bactiguard's portfolio. Initially, the agreement generates revenues of more than SEK 30 million in the form of product

ÅF does new dairy project for Arla

ÅF has received an order from Arla Foods to transform Falkenberg Dairy in Sweden into a new eco-friendly plant with new technology for recycling and processing of waste products. ÅF is responsible for the entire project and the order is worth SEK 63 million.“This is the largest order from Arla so far and proof of our ability to strengthen Arla’s competitiveness and create value in large complex projects,” says Robert Larsson, EVP and Head of Division Industry at ÅF. Falkenberg Dairy is Europe’s largest maker of cottage cheese and produces many varieties, including the KESO® brand. The

AcadeMedia signs a new loan agreement with a total amount of SEK 2,500 million

On Friday the 29th of June, 2018, AcadeMedia signed a new loan agreement with its financiers involving an extension of the total amount of SEK 2,500 million until the middle of 2023. The new loan agreement is expected to render approximately SEK 10 million lower interest expenses per year as well as improved financial flexibility. Since 2010 AcadeMedia has a loan agreement with Nordea and DNB. After a tender process AcadeMedia has entered into a new loan agreement with these financial institutions which will result in lower interest expenses of approximately SEK 10 million per annum and

Clavister Ramps up Sales Capacity in DACH

New sales professional hires will accelerate growth in the DACH region.ÖRNSKÖLDSVIK, SWEDEN. 2018-07-02. Clavister, a leader in high-performance cybersecurity solutions, has recently on-boarded an additional three highly skilled network security sales experts to the DACH (Germany, Austria, Switzerland) team. “We’re very happy to see the adding of these resources to our team,” states the Sales Director of Clavister DACH, Thomas Gross. “We’ve brought in new salespeople with solid experience from the security industry, and we have high expectations on them to help drive our commercial

Cxense appoints David Gosen as Chief Commercial Officer

Oslo, Norway – 2 July 2018 – Cxense ASA today announced that David Gosen has been appointed Chief Commercial Officer (CCO) of the company. David will be responsible for all commercial activities when he starts in August 2018. The appointment is part of the ongoing strategy to strengthen the Cxense management team and position the company for growth. Cxense provides clients such as Aeon, Wall Street Journal, Grupo Clarin, CBC and Univision with its Data Management Platform with Intelligent Personalization.   David is a proven commercial leader having held senior positions at Microsoft,

Veoneer is now an independent, publicly traded company

Stockholm, Sweden, July 2, 2018: The spin-off from Autoliv Inc. has been completed and Veoneer Inc. (NYSE: VNE and SSE: VNE SDB) is now an independent, publicly traded company, with listings on NYSE and Nasdaq Stockholm. Regular trading in Veoneer starts today. The start of Veoneer as a public company will be celebrated with bell ringing ceremonies at both stock exchanges.“Veoneer is the most focused active safety and autonomous driving company in the market. We have a unique combination of automotive grade experience and cutting-edge technology which makes us a sustainable leader in our

Lynparza approved in Japan for BRCAm breast cancer

02 July 2018 07:00BST Lynparza approved in Japan for BRCA-mutated metastatic breast cancer Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer Second approval in Japan for AstraZeneca and MSD's Lynparza AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has approved Lynparza (olaparib) tablets for use in patients with unresectable or recurrent BRCA-mutated (BRCAm), human epidermal growth factor receptor 2 (HER2)

REPURCHASED SHARES IN KARO PHARMA DURING WEEK 26 2018

During the period 25 June 2018 to 29 June 2018, Karo Pharma AB (publ) (LEI code 213800G54Z51LOPGTA79) has repurchased in total 460,816 own shares (ISIN: SE00007464888). The repurchases form part of the SEK 86.3 million share repurchase programme that Karo Pharma announced on 18 June 2018. The share repurchase programme, which runs between 18 June 2018 and 31 August 2018, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052.During the period 25 June 2018 – 29 June 2018, shares in Karo Pharma

Sterilization process for the excipient in SI-053 secured

Double Bond Pharmaceutical reports that transfer of the sterilization process for the excipient in SI-053 has been completed with satisfactory results. The process has been performed by a contract sterilization company in the EU. “This is an important step in the technology transfer process before manufacturing a GMP batch for our upcoming clinical trial” says Igor Lokot, CEO at Double Bond Pharmaceutical. This information is information that Double Bond Pharmaceutical International AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted

Etteplan continues its expansion in China with the opening of a new office

Etteplan’s operations have expanded further in China as the company opens its seventh office in the country. The new office is located in the city of Wuhan, in Hubei Province, central China. Wuhan lies in the middle reaches of the Yangtze River’s intersection with the Han river. The expansion to central China is related to the growing demand for Etteplan’s services among Chinese customers. Etteplan provides industrial equipment and machinery engineering services, embedded systems and IoT solutions (Internet of Things), and technical documentation solutions. The new office brings the

Preem and SAS in Cooperation on Renewable Aviation Fuel

Preem and SAS have today signed a letter of intent to produce renewable aviation fuel, known as biojet / biofuel. SAS has the ambition to replace today's fuel volume for domestic airplanes with biojet / biofuel by 2030.The letter of intent means that SAS and Preem will collaborate to jointly ensure the production of biojet / biofuel in connection with Preem's planned capacity expansion of the Gothenburg refinery. Preliminary estimated startup is 2022 and the total ethylene capacity for biofuels is estimated at over one million cubic meters, of which a subset can be Biojet / biofuel for

TECHSTEP ASA – NOTIFIABLE TRADING

Palos Norge AS (“Palos”) has today completed the transfer of in aggregate 7,544,444 shares (the “Shares”) in Techstep ASA (the “Company”) (the “Transfer”), corresponding to 5.16% of the total number of issued shares in the Company. The Shares were transferred to Palos’ shareholders, who has become direct owners of the Shares after the completion of the Transfer (and not through Palos). As a result of the Transfer, Palos’ ownership share has today fallen below 5% of the total number of issued shares in the Company, and comprises 4,122,223 shares, corresponding to 2.82% of the total

TECHSTEP ASA – NOTIFIABLE TRADING OF PRIMARY INSIDER

Reference is made to the previous announcement as of today relating to the transfer by Palos Norge AS (“Palos”) to its shareholders of 7,544,444 shares (the “Transfer”) in the Techstep ASA (the “Company”). As part of the Transfer, 1,287,245 shares in the Company were transferred today from Palos to Idekapital AS, a company controlled by Anders Brandt, member of the board of directors of the Company, at a price of NOK 3.08 per share. Following said transfer from Palos to Idekapital AS, Anders Brandt holds (through Idekapital AS) 1,287,245 shares in the Company, corresponding to 0.88%

There are no items matching the current filter
There are no more items matching the current filter
Back to top